Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × Paclitaxel × Clear all

NCT05420636 2025-07-30

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Phase 2 Terminated

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT00193531 2023-04-11

Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma

Phase 2 Completed

Carcinoma, Neuroendocrine